BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 29965974)

  • 1. Differential expression and function of CAIX and CAXII in breast cancer: A comparison between tumorgraft models and cells.
    Chen Z; Ai L; Mboge MY; Tu C; McKenna R; Brown KD; Heldermon CD; Frost SC
    PLoS One; 2018; 13(7):e0199476. PubMed ID: 29965974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and activity of carbonic anhydrase IX is associated with metabolic dysfunction in MDA-MB-231 breast cancer cells.
    Li Y; Wang H; Oosterwijk E; Tu C; Shiverick KT; Silverman DN; Frost SC
    Cancer Invest; 2009 Jul; 27(6):613-23. PubMed ID: 19367501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of carbonic anhydrase IX expression is distinct in various subtypes of breast cancer and its silencing suppresses self-renewal capacity of breast cancer cells.
    Ivanova L; Zandberga E; Siliņa K; Kalniņa Z; Ābols A; Endzeliņš E; Vendina I; Romanchikova N; Hegmane A; Trapencieris P; Eglītis J; Linē A
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):235-46. PubMed ID: 25422154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.
    Ilie M; Hofman V; Zangari J; Chiche J; Mouroux J; Mazure NM; Pouysségur J; Brest P; Hofman P
    Lung Cancer; 2013 Oct; 82(1):16-23. PubMed ID: 23910904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential CMS-Related Expression of Cell Surface Carbonic Anhydrases IX and XII in Colorectal Cancer Models-Implications for Therapy.
    Rotermund A; Brandt S; Staege MS; Luetzkendorf J; Mueller LP; Mueller T
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalysis and pH control by membrane-associated carbonic anhydrase IX in MDA-MB-231 breast cancer cells.
    Li Y; Tu C; Wang H; Silverman DN; Frost SC
    J Biol Chem; 2011 May; 286(18):15789-96. PubMed ID: 21454639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH.
    Chiche J; Ilc K; Laferrière J; Trottier E; Dayan F; Mazure NM; Brahimi-Horn MC; Pouysségur J
    Cancer Res; 2009 Jan; 69(1):358-68. PubMed ID: 19118021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
    Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J
    Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of carbonic anhydrase IX abrogates hypoxia-induced overexpression of stanniocalcin-1 in triple negative breast cancer cells.
    Zandberga E; Zayakin P; Ābols A; Pūpola D; Trapencieris P; Linē A
    Cancer Biol Ther; 2017 Aug; 18(8):596-605. PubMed ID: 28665755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors.
    Lou Y; McDonald PC; Oloumi A; Chia S; Ostlund C; Ahmadi A; Kyle A; Auf dem Keller U; Leung S; Huntsman D; Clarke B; Sutherland BW; Waterhouse D; Bally M; Roskelley C; Overall CM; Minchinton A; Pacchiano F; Carta F; Scozzafava A; Touisni N; Winum JY; Supuran CT; Dedhar S
    Cancer Res; 2011 May; 71(9):3364-76. PubMed ID: 21415165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy.
    McIntyre A; Patiar S; Wigfield S; Li JL; Ledaki I; Turley H; Leek R; Snell C; Gatter K; Sly WS; Vaughan-Jones RD; Swietach P; Harris AL
    Clin Cancer Res; 2012 Jun; 18(11):3100-11. PubMed ID: 22498007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche.
    Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S
    Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway.
    Hsieh MJ; Chen KS; Chiou HL; Hsieh YS
    Eur J Cell Biol; 2010 Aug; 89(8):598-606. PubMed ID: 20434230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of carbonic anhydrase IX expression in prediction of the efficacy and outcome of primary epirubicin/tamoxifen therapy for breast cancer.
    Generali D; Fox SB; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield SM; Bruzzi P; Bersiga A; Allevi G; Milani M; Aguggini S; Dogliotti L; Bottini A; Harris AL
    Endocr Relat Cancer; 2006 Sep; 13(3):921-30. PubMed ID: 16954440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of cellular and serum carbonic anhydrase IX in primary breast cancer.
    Schütze D; Milde-Langosch K; Witzel I; Rody A; Karn T; Schmidt M; Choschzick M; Jänicke F; Müller V
    J Cancer Res Clin Oncol; 2013 May; 139(5):747-54. PubMed ID: 23358720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of pH regulation as a therapeutic strategy in hypoxic human breast cancer cells.
    Meehan J; Ward C; Turnbull A; Bukowski-Wills J; Finch AJ; Jarman EJ; Xintaropoulou C; Martinez-Perez C; Gray M; Pearson M; Mullen P; Supuran CT; Carta F; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2017 Jun; 8(26):42857-42875. PubMed ID: 28476026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of in vitro breast cancer models.
    Ward C; Meehan J; Mullen P; Supuran C; Dixon JM; Thomas JS; Winum JY; Lambin P; Dubois L; Pavathaneni NK; Jarman EJ; Renshaw L; Um IH; Kay C; Harrison DJ; Kunkler IH; Langdon SP
    Oncotarget; 2015 Sep; 6(28):24856-70. PubMed ID: 26259239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLUT1 and CAIX expression profiles in breast cancer correlate with adverse prognostic factors and MCT1 overexpression.
    Pinheiro C; Sousa B; Albergaria A; Paredes J; Dufloth R; Vieira D; Schmitt F; Baltazar F
    Histol Histopathol; 2011 Oct; 26(10):1279-86. PubMed ID: 21870331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of transmembrane carbonic anhydrases, CAIX and CAXII, in human development.
    Liao SY; Lerman MI; Stanbridge EJ
    BMC Dev Biol; 2009 Mar; 9():22. PubMed ID: 19291313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.